A 26-week, prospective, open-label, uncontrolled, multicenter study to evaluate the effect of an escalating-dose regimen of trandolapril on change in blood pressure in treatment-naive and concurrently treated adult hypertensive subjects (TRAIL).
A 26-week prospective, open-label, uncontrolled, multicenter study to assess the effect of an increasing dose regimen of transdolapril on change in blood pressure in treatment-naive and treated adult hypertensive subjects (TRAIL)